Anxo Pharmaceutical Co., Ltd. 6677.TWO Stock
Anxo Pharmaceutical Co., Ltd. Price Chart
Anxo Pharmaceutical Co., Ltd. 6677.TWO Financial and Trading Overview
| Anxo Pharmaceutical Co., Ltd. stock price | 45.45 TWD |
| Previous Close | 62 TWD |
| Open | 63.1 TWD |
| Bid | 62.4 TWD x 0 |
| Ask | 63.2 TWD x 0 |
| Day's Range | 60.8 - 65.1 TWD |
| 52 Week Range | 18.4 - 67.7 TWD |
| Volume | 331.88K TWD |
| Avg. Volume | 319.3K TWD |
| Market Cap | 3.04B TWD |
| Beta (5Y Monthly) | -0.105962 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.67 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | July 2, 2020 |
| 1y Target Est | N/A |
6677.TWO Valuation Measures
| Enterprise Value | 3.74B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.5138593 |
| Price/Book (mrq) | 4.1993356 |
| Enterprise Value/Revenue | 4.314 |
| Enterprise Value/EBITDA | 54.53 |
Trading Information
Anxo Pharmaceutical Co., Ltd. Stock Price History
| Beta (5Y Monthly) | -0.105962 |
| 52-Week Change | 210.05% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 67.7 TWD |
| 52 Week Low | 18.4 TWD |
| 50-Day Moving Average | 51.37 TWD |
| 200-Day Moving Average | 35.52 TWD |
6677.TWO Share Statistics
| Avg. Volume (3 month) | 319.3K TWD |
| Avg. Daily Volume (10-Days) | 904.14K TWD |
| Shares Outstanding | 48.16M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1050:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -1.45% |
| Operating Margin (ttm) | 0.68% |
| Gross Margin | 38.26% |
| EBITDA Margin | 7.91% |
Management Effectiveness
| Return on Assets (ttm) | 0.19% |
| Return on Equity (ttm) | -0.84% |
Income Statement
| Revenue (ttm) | 866.27M TWD |
| Revenue Per Share (ttm) | 17.99 TWD |
| Quarterly Revenue Growth (yoy) | 17.19% |
| Gross Profit (ttm) | N/A |
| EBITDA | 68.53M TWD |
| Net Income Avi to Common (ttm) | -12558000 TWD |
| Diluted EPS (ttm) | -0.25 |
| Quarterly Earnings Growth (yoy) | 46.00% |
Balance Sheet
| Total Cash (mrq) | 241.32M TWD |
| Total Cash Per Share (mrq) | 5.01 TWD |
| Total Debt (mrq) | 887.09M TWD |
| Total Debt/Equity (mrq) | 106.93 TWD |
| Current Ratio (mrq) | 1.39 |
| Book Value Per Share (mrq) | 15.05 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 71.42M TWD |
| Levered Free Cash Flow (ttm) | 62.13M TWD |
Profile of Anxo Pharmaceutical Co., Ltd.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No.206, Nanking East Road |
| ZIP | 10489 |
| Phone | 886 2 2504 2121 |
| Website | https://www.anxo.com.tw |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally. It offers prescription and over the counter drugs in various therapeutic areas, such as cardiovascular, metabolism, CNS, diabetic, gastroenterology, respiratory, anti-infection, dermatology, nephrology, urology, orthopedics, etc. The company was founded in 2003 and is headquartered in Taipei, Taiwan.
Q&A For Anxo Pharmaceutical Co., Ltd. Stock
What is a current 6677.TWO stock price?
Anxo Pharmaceutical Co., Ltd. 6677.TWO stock price today per share is 45.45 TWD.
How to purchase Anxo Pharmaceutical Co., Ltd. stock?
You can buy 6677.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Anxo Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Anxo Pharmaceutical Co., Ltd. is 6677.TWO.
Which industry does the Anxo Pharmaceutical Co., Ltd. company belong to?
The Anxo Pharmaceutical Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Anxo Pharmaceutical Co., Ltd. have in circulation?
The max supply of Anxo Pharmaceutical Co., Ltd. shares is 55.66M.
What is Anxo Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Anxo Pharmaceutical Co., Ltd. PE Ratio is 67.83582000 now.
What was Anxo Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Anxo Pharmaceutical Co., Ltd. EPS is 0.67 TWD over the trailing 12 months.
Which sector does the Anxo Pharmaceutical Co., Ltd. company belong to?
The Anxo Pharmaceutical Co., Ltd. sector is Healthcare.